ALISO
VIEJO, Calif., Jan. 8, 2024
/PRNewswire/ -- Okami Medical Inc., a medical device company
focused on developing innovative solutions that address key unmet
clinical needs in peripheral vascular intervention, today announced
the appointment of Rhonda Robb as
President and Chief Executive Officer.
Rhonda is a proven medical device executive with more than 25
years of leadership and commercial experience. She most recently
served as Chief Operating Officer at Cardiovascular Systems, Inc.,
a leader in the treatment of peripheral and coronary artery
disease. Prior to Cardiovascular Systems, Rhonda served as the Vice
President and General Manager for Heart Valve Therapies at
Medtronic, where she led the transcatheter and surgical heart valve
franchises. She also serves on the Board of Directors for 4C
Medical.
"Rhonda brings a proven track record and a wealth of experience
to the company," said Bob
Rosenbluth, PhD, Co-Founder and Chairman of the Board of
Okami Medical. "She shares our commitment and passion for providing
patients and physicians with access to advanced technologies that
address the numerous challenges in peripheral vascular occlusion.
We are thrilled to have her leading the company into the next phase
of expansion and growth."
"I am honored to have the opportunity to lead Okami Medical at
this exciting time as we prepare to commercialize our LOBO Vascular
Occlusion System," said Rhonda. "The team has done a tremendous job
of taking the system from the conceptual stage through clinical
validation. LOBO is a next-generation technology that is delivering
remarkable clinical performance and is uniquely suited to transform
and expand the treatment of patients suffering from peripheral
vascular conditions."
About Okami Medical, Inc.
Okami Medical, Inc. is a privately-held medical device company
focused on developing innovative solutions that address key unmet
clinical needs in peripheral vascular intervention. Okami is the
second portfolio company of Inceptus Medical LLC, a medical device
incubator. Inari Medical, Inc. (NASDAQ: NARI), Inceptus' first
portfolio company, is pioneering approaches to treat venous
thromboembolism and other diseases. Okami is backed by members of
the board of directors, U.S. Venture Partners (www.usvp.com) and
medical device industry veterans. For more information, please
visit www.okamimedical.com.
Source:
Okami Medical, Inc.
949-446-9710
info@okamimedical.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/okami-medical-appoints-rhonda-robb-as-president-and-chief-executive-officer-302027577.html
SOURCE Okami Medical Inc.